Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1990 Mar;87(5):1932-6.
doi: 10.1073/pnas.87.5.1932.

Cannabinoid Receptor Localization in Brain

Affiliations
Free PMC article
Comparative Study

Cannabinoid Receptor Localization in Brain

M Herkenham et al. Proc Natl Acad Sci U S A. .
Free PMC article

Abstract

[3H]CP 55,940, a radiolabeled synthetic cannabinoid, which is 10-100 times more potent in vivo than delta 9-tetrahydrocannabinol, was used to characterize and localize a specific cannabinoid receptor in brain sections. The potencies of a series of natural and synthetic cannabinoids as competitors of [3H]CP 55,940 binding correlated closely with their relative potencies in several biological assays, suggesting that the receptor characterized in our in vitro assay is the same receptor that mediates behavioral and pharmacological effects of cannabinoids, including human subjective experience. Autoradiography of cannabinoid receptors in brain sections from several mammalian species, including human, reveals a unique and conserved distribution; binding is most dense in outflow nuclei of the basal ganglia--the substantia nigra pars reticulata and globus pallidus--and in the hippocampus and cerebellum. Generally high densities in forebrain and cerebellum implicate roles for cannabinoids in cognition and movement. Sparse densities in lower brainstem areas controlling cardiovascular and respiratory functions may explain why high doses of delta 9-tetrahydrocannabinol are not lethal.

Similar articles

See all similar articles

Cited by 515 articles

See all "Cited by" articles

References

    1. J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):413S-416S - PubMed
    1. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
    1. Ann Neurol. 1983 Jun;13(6):669-71 - PubMed
    1. Neuropeptides. 1983 Oct;3(6):493-9 - PubMed
    1. J Neurosci. 1984 Aug;4(8):2133-44 - PubMed

Publication types

LinkOut - more resources

Feedback